111 related articles for article (PubMed ID: 17166518)
1. Platelet imidazoline receptors as state marker of depressive symptomatology.
Piletz J; Baker R; Halaris A
J Psychiatr Res; 2008 Jan; 42(1):41-9. PubMed ID: 17166518
[TBL] [Abstract][Full Text] [Related]
2. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder.
Piletz JE; Halaris A; Nelson J; Qu Y; Bari M
J Psychiatr Res; 1996; 30(3):147-68. PubMed ID: 8884655
[TBL] [Abstract][Full Text] [Related]
3. Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients.
Piletz JE; Halaris AE; Chikkala D; Qu Y
J Psychiatr Res; 1996; 30(3):169-84. PubMed ID: 8884656
[TBL] [Abstract][Full Text] [Related]
4. Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients.
Piletz JE; Halaris A; Saran A; Marler MR
Arch Gen Psychiatry; 1991 Sep; 48(9):813-20. PubMed ID: 1681792
[TBL] [Abstract][Full Text] [Related]
5. Platelet alpha 2-adrenergic receptors in depressed patients and healthy volunteers: the effects of desipramine.
Werstiuk ES; Auffarth SE; Coote M; Gupta RN; Steiner M
Pharmacopsychiatry; 1992 Jul; 25(4):199-206. PubMed ID: 1326772
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment.
Halaris A; Zhu H; Ali J; Nasrallah A; Lindsay De Vane C; Piletz JE
Int J Neuropsychopharmacol; 2002 Mar; 5(1):37-46. PubMed ID: 12057030
[TBL] [Abstract][Full Text] [Related]
7. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes.
Halbreich U; Piletz JE; Carson S; Halaris A; Rojansky N
Biol Psychiatry; 1993 Nov; 34(10):676-86. PubMed ID: 7904832
[TBL] [Abstract][Full Text] [Related]
8. Platelet [3H]imipramine and alpha 2-adrenoceptor binding in normal subjects during desipramine administration and withdrawal.
Healy DT; Paykel ES; Whitehouse AM; White W; Wilton-Cox H; Johnson AL; Theodorou AE; Lawrence K; Horton RW
Neuropsychopharmacology; 1991 Feb; 4(2):117-24. PubMed ID: 1851012
[TBL] [Abstract][Full Text] [Related]
9. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
Coote M; Wilkins A; Werstiuk ES; Steiner M
J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
[TBL] [Abstract][Full Text] [Related]
10. Super high affinity 3H-para-aminoclonidine binding to platelet adrenoceptors in depression.
Piletz JE; Halaris A
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):541-53. PubMed ID: 2900540
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of platelet α2-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses.
Hikasa Y; Masuda K; Asakura Y; Yamashita Y; Sato C; Kamio M; Miura A; Taniguchi T; Minamizuru N
Eur J Pharmacol; 2013 Nov; 720(1-3):363-75. PubMed ID: 24120658
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
Piletz JE; Zhu H; Chikkala DN
J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
[TBL] [Abstract][Full Text] [Related]
13. Plasma agmatine and platelet imidazoline receptors in depression.
Halaris A; Zhu H; Feng Y; Piletz JE
Ann N Y Acad Sci; 1999 Jun; 881():445-51. PubMed ID: 10415948
[TBL] [Abstract][Full Text] [Related]
14. Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients.
Zhu H; Halaris A; Madakasira S; Pazzaglia P; Goldman N; DeVane CL; Andrew M; Reis D; Piletz JE
J Psychiatr Res; 1999; 33(4):323-33. PubMed ID: 10404470
[TBL] [Abstract][Full Text] [Related]
15. Increased 3H-clonidine binding in the platelets of patients with depressive and schizophrenic disorders.
Pandey GN; Janicak PG; Javaid JI; Davis JM
Psychiatry Res; 1989 Apr; 28(1):73-88. PubMed ID: 2544917
[TBL] [Abstract][Full Text] [Related]
16. Elevated 3H-para-aminoclonidine binding to platelet purified plasma membranes from depressed patients.
Piletz JE; Halaris A; Saran A; Marler M
Neuropsychopharmacology; 1990 Jun; 3(3):201-10. PubMed ID: 1973039
[TBL] [Abstract][Full Text] [Related]
17. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims.
García-Sevilla JA; Escribá PV; Sastre M; Walzer C; Busquets X; Jaquet G; Reis DJ; Guimón J
Arch Gen Psychiatry; 1996 Sep; 53(9):803-10. PubMed ID: 8792757
[TBL] [Abstract][Full Text] [Related]
18. Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy.
Piletz JE; Halbreich U
Biol Psychiatry; 2000 Nov; 48(9):932-9. PubMed ID: 11074231
[TBL] [Abstract][Full Text] [Related]
19. Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone.
Yatham LN; Liddle PF; Dennie J; Shiah IS; Adam MJ; Lane CJ; Lam RW; Ruth TJ
Arch Gen Psychiatry; 1999 Aug; 56(8):705-11. PubMed ID: 10435604
[TBL] [Abstract][Full Text] [Related]
20. Platelet membrane alpha 2-adrenergic receptors in depression.
Karege F; Bovier P; Widmer J; Gaillard JM; Tissot R
Psychiatry Res; 1992 Sep; 43(3):243-52. PubMed ID: 1359596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
